# DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
> **ANDA211583** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2026-04-06
## Drug
- **FDA Application Number:** ANDA211583
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Dapagliflozin
- **Active ingredients:** DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2026-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211583)
---
*AI Analytics · CC0 1.0*